Merzel

Brand Name:

Merzel

Generic Name:

Meropenem

Composition:

Merzel Injection 500mg IV: Each pack contains:
Vial: Meropenem 500mg (Blended with Sterile Sodium Carbonate).
Ampoule: Sterile water for injection 10mL.
Merzel Injection 1g IV: Each pack contains:
Vial: Meropenem 1g (Blended with Sterile Sodium Carbonate).
Ampoule: Sterile water for injection 10mL (2 Ampoules).

DESCRIPTION:

DESCRIPTION Merzel IV (meropenem for injection) is a sterile, pyrogen-free, synthetic, carbapenem antibacterial for intravenous administration. When re-constituted as instructed, each 1 g Merzel IV vial will deliver 1 g of meropenem and 90.2 mg of sodium as sodium carbonate (3.92 mEq). Each 500 mg Merzel IV vial will deliver 500 mg meropenem and 45.1 mg of sodium as sodium carbonate (1.96 mEq).

INDICATIONS:

Complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older only)
Merzel IV is indicated for the treatment of complicated skin and skin structure infections due to Staphylococcus aureus (methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (vancomycin-susceptible isolates only), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis, and Peptostreptococcus species.
Complicated intra-abdominal infections (adult and pediatric patients)
For the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species.
Bacterial meningitis (pediatric patients 3 months of age and older only)
Merzel IV is indicated for the treatment of bacterial meningitis caused by Haemophilus influenzae, Neisseria meningitidis and penicillin-susceptible isolates of Streptococcus pneumoniae. Merzel IV has been found to be effective in eliminating concurrent bacteremia in association with bacterial meningitis.
Usage
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Merzel IV and other antibacterial drugs, Merzel IV should only be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.

PRESENTATION:

Merzel 500mg IV Injection 1 vial of 500 mg meropenem and 1 ampoule of 10mL solvent.
Merzel 1g IV Injection 1 vial of 1 g meropenem and 2 ampoules with10mL solvent each.

Hitase

Brand Name:

Hitase

Generic Name:

Letrozole

DESCRIPTION:

HITASE is an aromatase inhibitor. It works by decreasing the amount of estrogen hormone our body makes.

INDICATIONS:

Hitase is an aromatase inhibitor indicated for:

Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
Extended adjuvant treatment of postmenopausal women with early breast cancer who has received prior standard adjuvant tamoxifen therapy.
First and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer.

PRESENTATION:

Hitase 2.5mg tablets: Alu. Alu. Packs of 1* 10’s

Cuziper

Brand Name:

Cuziper

Generic Name:

Bisoprolol Fumarate

Composition:

Cuziper 2.5mg tablet:
Each film-coated tablet contains,
2.5mg Bisoprolol Fumarate
Cuziper 5mg tablet:
Each film-coated tablet contains,
5mg Bisoprolol Fumarate
Cuziper 10mg tablet:
Each film-coated tablet contains,
10mg Bisoprolol Fumarate

DESCRIPTION:

Cuziper, Bisoprolol fumarate is a synthetic, beta 1 selective (Cardioselective) adrenoceptor blocking agent.

INDICATIONS:

Treatment of Hypertension, Treatment of stable chronic angina.
Treatment of stable chronic heart failure (CHF) with reduced systolic left ventricular

PRESENTATION:

Cuziper 2.5mg film-coated tablet, Alu PVC blister pack of 14 * 1’s & Cuziper 5mg, Cuziper 10mg film-coated tablet, Alu PVC blister pack of 10 * 2’s.

Daploz

Brand Name:

Daploz

Generic Name:

Dapagliflozin

Composition:

Daploz 5mg Tablet: Each film-coated tablet contai Dapagliflozin (as Propanediol Monohydrate) 5mg
Daploz 10mg Tablet: Each film-coated tablet conte Dapaaliflozin (as Propanediol Monohydrate) 10mg

Description:

Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor indicated for managing diabetes mellitus type 2. When combined with diet and exercise in adults, dapagliflozin helps to improve glycemic control by inhibiting glucose resorption in the proximal tubule of the nephron and causing glycosuria.

INDICATIONS:

Daploz/Daplozmet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular disease or multiple cardiovascular risk factors Daploz/Daplozmet is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.

PRESENTATION:

Daploz 5 mg tablets: Alu. Alu. blister pack of 2 x 7’s. Daploz 10 mg tablets: Alu. Alu. blister pack of 2 x 7’s. Daplozmet 5/850 mg tablets: Alu. Alu. blister pack of 2 x 7’s. Daplozmet 5/1000 mg tablets: Alu. Alu. blister pack of 2 x 7’s.

Patients should consult with their physician before taking any medicine.

Daplozmet

Brand Name:

Daplozmet

Generic Name:

Dapagliflozin + MetFormin HCI

Composition:

Daplozmet 5/850mg Tablet: Each film-coated tablet contains.
Dapagliflozin (as Dapagliflozin Propanediol Monohydrate) 5mg
Metformin Hydrochloride 850mg
Daplozmet 5/1000mg Tablet: Each film coated tablet contains Dapagliflozin (as Dapagliflozin Propanediol Monohydrate) 5mg
Metformin Hydrochloride 1000mg

Description:

INDICATIONS:

PRESENTATION:

Daplozmet 5/850 mg tablets: Alu. Alu. blister pack of 2 x 7’s. Daplozmet 5/1000 mg tablets: Alu. Alu. blister pack of 2 x 7’s.

Daplozmet XR

Brand Name:

Daplozmet XR

Generic Name:

Dapagliflozin + Metformin HCI

Composition:

Daplozmet XR 5mg/500mg:Each bi-layered film-coated tablet contains: Dapagliflozin as Propanediol Monohydrate (immediate release) 5mg Metformin HCI (extended release) 500mg

Daplozmet XR 5mg/1000mg Tablet: Each bi-layered film-coated tablet contains: Dapagliflozin as Propanediol Monohydrate (immediate release) 5mg Metformin HCI (extended release) 1000mg

Daplozmet XR 10mg/500mg Tablet: Each bi-layered Film-coated tablet contains: Dapagliflozin as Propanediol Monohydrate (immediate release) 10mg Metformin HCI (extended release) 500mg

Daplozmet XR 10mg/1000mg Tablet: Each bi-layered Film-coated tablet contains: Dapagliflozin as Propanediol Monohydrate (immediate release) 10mg Metformin HCI (extended release) 1000mg

DESCRIPTION:

It contains Dapagliflozin, a SGLT2 inhibitor, and Metformin HCI, a biguanide.

INDICATIONS:

Indications:
It is indicated as an adjunct to diet and exercise to improve Glycaemic control in adults with type 2 diabetes mellitus:
In patients insufficiently controlled on their maximally tolerated dose of metformin alone
In combination with other medicinal products for the treatment of diabetes in patients insufficiently controlled with metformin and these medicinal products
In patients already being treated with the combination of Dapagliflozin and metformin as separate tablets.
Dapagliflozin is indicated to reduce:
The risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors.
The risk of cardiovascular death and hospitalization for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction.
The risk of sustained estimated glomerular filtration rate decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression.

PRESENTATION:

Daplozmet XR 5/500mg Tablets:
Alu. Alu. Blister pack of 2 x 7’s.
Daplozmet XR 5/1000mg Tablets:
Alu. Alu. Blister pack of 2 x 7’s.
Daplozmet XR 10/500mg Tablets:
Alu. Alu. Blister pack of 2 x 7’s.
Daplozmet XR 10/1000mg Tablets:
Alu. Alu. Blister pack of 2 x 7’s.

Diajard

Brand Name:

Diajard

Generic Name:

Empagliflozin

Composition:

Diajard 10mg Tablet: Each film-coated tablet contains:
Empagliflozin 10mg
Diajard 25mg Tablet: Each film-coated tablet contains:
Empagliflozin 25mg

DESCRIPTION:

Diajard (Empagliflozin) is a prescription medicine used to treat:

Diabetes Mellitus Type-2

INDICATIONS:

Diabetes Type-2 patients on prescription of a doctor

PRESENTATION:

Diajard is presented in 10 mg & 25 mg tablets

Diajard-M

Brand Name:

Diajard-M

Generic Name:

Empagliflozin + Metformin HCI

Composition:

Diajard-M 5mg/500mg Tablet:
Each film-coated tablet contains: Empagliflozin 5mg
Metformin HCI 500 mg
Diajard-M 12.5mg/500mg Tablet:
Each film-coated tablet contains: Empagliflozin 12.5m
Metformin HCI 500mg
Diajard-M 5mg/1000mg Tablet:
Each film-coated tablet contains: Empagliflozin 5mg
Metformin HCI 1000 mg
Diajard-M 12.5mg/1000mg Tablet:
Each film-coated tablet contains: Empagliflozin 12.5 m
Metformin HCI 1000mg

DESCRIPTION:

Diajard-M (Empaglifozin+Metformin) is a prescription medicine used to: Diabetes Mellitus Type-2

INDICATIONS:

Diabetes Type-2 patients on prescription of a doctor

PRESENTATION:

Diajard-M is presented in 5/500, 5/1000, 12.5/500 or 12.5/1000

Diajard-MXR

Brand Name:

Diajard-MXR

Generic Name:

Empagliflozin + Metformin HCI Extended-release

Composition:

Diajard-MXR 5mg/1000mg Tablet:
Each film-coated tablet contains:
Empagliflozin (as immediate-release layer) 5mg
Metformin HCI (as extended-release layer) 1000mg
Diajard-MXR 10mg/1000mg Tablet:
Each film-coated tablet contains:
Empagliflozin (as immediate-release layer) 10mg
Metformin HCI (as extended-release layer) 1000 mg
Diajard-MXR 12.5mg/1000mg Tablet:
Each film-coated tablet contains:
Empagliflozin (as immediate-release laver) 12.5mg
Metformin HCI (as extended-release layer) 1000mg
Diajard-MXR 25mg/1000mg tablet:
Each film-coated tablet contains:
Empagliflozin (as immediate-release layer) 25 mg
Metformin HCI (as extended-release layer) 1000mg

DESCRIPTION:

Diajard-MXR (Empaglifozin+Metformin extended release) is a prescription medicine used to: Diabetes Mellitus Type-2

INDICATIONS:

Diabetes Type-2 patients on prescription of a doctor

PRESENTATION:

Diajard-MXR is presented in , 5/1000, 10/1000, 12.5/500 or 25/1000 mg

Tagip

Brand Name:

Tagip

Generic Name:

Sitagliptin

Composition:

Tagip 25mg Tablet:
Each film-coated tablet contains Sitagliptin Phosphate
Monohydrate equivalent to Sitagliptin 25mg
Tagip 50mg Tablet:
Each film-coated tablet contains Sitagliptin Phosphate
Monohydrate equivalent to Sitagliptin 50mg
Tagip 100mg Tablet:
Each film-coated tablet contains Sitagliptin Phosphate
Monohydrate equivalent to Sitagliptin 100mg

Description:

Tagip (Sitagliptin) is a prescription medicine used to treat Diabetes Mellitus Type-2

INDICATIONS:

Diabetes Type-2 patients on prescription of a doctor

PRESENTATION:

Tagip is presented in 25mg, 50mg, and 100mg tablets

Tagipmet

BRAND NAME:

Tagipmet

GENERIC NAME:

Sitagliptin + Metformin HCl

COMPOSITION

Tagipmet 50mg/500mg Tablet: Each Film-coated tablet contains:
Sitagliptin (as phosphate monohydrate) 50mg
Metformin HCI 500mg
Tagipmet 50mg/1000mg Tablet: Each Film-coated tablet contains:
Sitagliptin (as phosphate monohydrate) 50mg
Metformin HCI 1000mg

DESCRIPTION:

Tagipmet (Sitagliptin + Metformin) is a prescription medicine used to treat: Diabetes Mellitus Type-2

INDICATION:

Diabetes Type-2 patients on prescription of a doctor

PRESENTATION:

Tagipmet is presented in 50mg/500mg and 50mg/1000mg tablets

Tagipmet XR

BRAND NAME:

Tagipmet XR

GENERIC NAME:

Sitagliptin + Metformin HCI Sustained Release

COMPOSITION

Tagipmet XR 50/500mg Tablet: Each Tablet contains:
Sitagliptin (as phosphate monohydrate) 50mg
Metformin HCI sustained-release 500mg
Tagipmet XR 50/1000mg Tablet: Each Tablet contains:
Sitagliptin (as phosphate monohydrate) 50mg
Metformin HCI sustained-release 1000mg
Tagipmet XR 100/1000mg Tablet: Each Tablet contains:
Sitagliptin (as phosphate monohydrate) 100 mg
Metformin HCI sustained-release 1000mg

DESCRIPTION:

Tagipmet-XR(Sitagliptin+Metformin extended release) is a prescription medicine used to treat:
Diabetes Mellitus Type-2

INDICATION:

Diabetes Type-2 patients on prescription of a doctor

PRESENTATION:

TAGIPMET XR is presented in 50/500, 50/1000 & 100/1000 respectively

Nylomet

Brand Name:

Nylomet

Generic Name:

Glimepiride + Metformin HCI

COMPOSITION:

Nylomet 1mg/500mgTablet:
Each film-coated tablet contains:
Glimepirdie 1mg
Metformin HCI 5000mg
Nylomet 2mg/500mgTablet:
Each film-coated tablet contains:
Glimepirdie 2mg
Metformin HCI 5000mg

DESCRIPTION:

Nylomet is a prescription medicine used to treat: Diabetes Mellitus Type-2

INDICATIONS:

Diabetes Type-2 patients on prescription of a doctor

PRESENTATION:

Nylomet 1mg/500mg or 2/500mg Film Coated Tablets: Blister Pack of 3×10’s

Glynvair

Brand Name:

Glynvair

Generic Name:

Glycopyrronium

COMPOSITION:

Each capsule contains:
Glycopyrronium (as Bromide) 50mcg
Each delivered dose contains:
Glycopyrronium (as Bromide) 44mcg

DESCRIPTION:

Glycopyrronium is a competitive antagonist at muscarinic acetylcholine receptors and belongs to the class of drugs known as anticholinergics.
It has a rapid onset of action within 5 minutes after inhalation.
It is slowly dissociated from muscarinic receptors, leading to a long duration of 24 hours.

INDICATIONS:

Once-daily maintenance bronchodilator treatment to relieve symptoms of patients with Chronic Obstructive Pulmonary Disease (COPD) Group A.
Add on therapy in patients of Asthma whose Asthma is uncontrolled with ICS/LABA treatment.

PRESENTATION:

Glynvair Rotacaps: Alu. Alu. Blister Pack of 3 x 10’s.

Betatec

Brand Name:

Betatec

Generic Name:

Beclomethasone Dipropionate

COMPOSITION:

Betatec 400 Rotacaps:
Each capsule contains:
Beclomethasone Dipropionate 400 mcg
Each delivered dose contains:
Beclomethasone Dipropionate 360 mcg

DESCRIPTION:

Beclomethasone Dipropionate is a synthetic glucocorticoid with a potent anti-inflammatory activity and weak mineralocorticoid activity. Beclomethasone Dipropionate given by inhalation has a potent anti- inflammatory action within the lungs but does not cause adverse systemic glucocorticoid effects at therapeutic doses

INDICATIONS:

Indicated for maintenance treatment of Asthma as prophylactic therapy and adjunct in combination to manage COPD Group E patients with any hospitalizations, ≥ 2 exacerbations per year requiring ICS, or blood eosinophils ≥300/ul.

PRESENTATION:

Betatec Rotacaps Alu Alu Blister Pack of 3 x 10’s.

Ultivair

Brand Name:

Ultivair

Generic Name:

Glycopyrronium + Indacaterol

COMPOSITION:

Each capsule contains:
Glycopyrronium (as Bromide) 50mcg
Indacaterol (as Maleate) 110mcg
Each delivered dose contains:
Glycopyrronium (as Bromide) 43mcg
Indacaterol (as Maleate) 85mcg

DESCRIPTION:

Ultivair contains two medications glycopyrronium and indacaterol.
Glycopyrronium belongs to the group of medications known as anticholinergics.
Indacaterol belongs to the group of medications known as long-acting bronchodilators.
These medications work in different ways to relax the muscles in the walls of the small air passages in the lungs, keeping the air passage open and making it easier to breathe.

INDICATIONS:

Once-daily maintenance bronchodilator treatment to relieve symptoms of patients with Chronic Obstructive Pulmonary Disease (Group B & Group E).

PRESENTATION:

Ultivair Rotacaps: Alu. Alu. Blister Pack of 3 x 10’s.

Powerhaler

Brand Name:

Powerhaler

Generic Name:

Powerhaler

DESCRIPTION:

Powerhaler is a novel DPI device, which has been designed and developed to address the critical requirements of an ideal inhalation device. Powerhaler is the First Double Air Course Inhalation Device, adding convenience for the patients and providing improved compliance for the patients

INDICATIONS:

Powerhaler is an easy-to-use and a preferred device in patients with mild asthma and COPD, as well as in healthy participants with no previous experience of using inhalation devices.

PRESENTATION:

Powerhaler: Pack of 1’s.
Patients should consult with their physician before taking any inhaler device.

Kydor

Brand Name:

Kydor

Generic Name:

Ketorolac Tromethamine

Composition:

Each 01 ml ampoule contains
Ketorolac Tromethamine 30mg

DESCRIPTION:

Ketorolac Tromethamine is a member of the pyrrolo-pyrrole group of nonsteroidal anti-
inflammatory drugs (nsaids). The chemical name for ketorolac tromethamine is (±)-5-
benzoyl-2,3-dihydro-1h-pyrrolizine-1- carboxylic acid, compound with 2-amino-2
(hydroxymethyl)-1,3-propanediol (1:1). Its molecular formula is C15 H 13 NO3. C 4 H
11 NO3. Structural formula is

INDICATIONS:

For short term management of moderate to severe pain.

PRESENTATION:

Kydor 30Mg IM/IV injection
PVC Blister, Pack Of 1ml X 5’s

Seden-P

Brand Name:

Seden-P

Generic Name:

Tramadol HCL + Paracetamol

Composition:

Each film-coated tablet contains:
Tramadol HCL 37.5mg
Paracetamol 325mg

Description:

Seden-P contains two analgesics, tramadol hydrochloride an opioid agonist, and paracetamol.

INDICATIONS:

It is indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
It is for short-term use of five days or less. Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, reserve its use in patients for whom alternative treatment options (e.g., non-opioid analgesics) have not been tolerated, or are not expected to be tolerated or have not provided adequate analgesia, or are not expected to provide adequate analgesia.

PRESENTATION:

Seden-P 37.5mg/325mg tablets: Alu. PVC. Blister pack of 2 x 5’s.

Combivair Forte

Brand Name:

Combivair Forte

Generic Name:

Budesonide + Formoterol Fumarate

Composition:

Combivair Forte Rotacap:

Each capsule contains:

Budesonide 400mcg

Formoterol Fumarate (as Dihydrate) 12mcg

DESCRIPTION:

Combivair Forte Rotacap is a combination of budesonide, a potent glucocorticoid and formoterol, a selective long-acting beta 2 -agonist. Budesonide is a potent glucocorticoid that binds with high affinity to the glucocorticoid receptor. It has a high ratio of topical to systemic activity. Formoterol is a very potent long-acting beta 2-agonist with a high intrinsic activity and a rapid onset of action.

INDICATIONS:

Combivair Forte Rotacap is indicated in the regular treatment of asthma, where use of a combination (long-acting beta -agonist and inhaled 2 corticosteroid) has been found to be appropriate. Symptomatic treatment of severe chronic obstructive pulmonary disease (COPD) with a history of repeated exacerbations despite regular therapy with long-acting bronchodilators. It is not indicated for the relief of acute bronchospasm.

PRESENTATION:

Combivair Forte Rotacaps: Blister pack of 3 X 10’s rotacaps

Patients should consult with their physician before taking any medicine.

Pirfenox 200mg

Brand Name:

Pirfenox 200mg

Generic Name:

Pirfenidone

Composition:

Pirfenox 200mg Tablet:
Each film-coated tablet contains: Pirfenidone 200mg

DESCRIPTION:

Pirfenox tablets contain the active substance pirfenidone which is used for the treatment of mild-to-moderate idiopathic pulmonary fibrosis (IPF) in adults. IPF is a condition in which the tissues of lungs become swollen and scarred over time and, as a result, it becomes difficult to breathe deeply. This makes it hard for the lungs to work properly. Pirfenox helps to reduce scarring and swelling in the lungs and helps the patient to breathe better.

INDICATIONS:

Idiopathic pulmonary fibrosis (IPF)

PRESENTATION:

Pirfenox 200mg tablets:

Alu-Alu Blister of 3 X 10’s

Alu-Alu Blister of 5 X 10’s

Patients should consult with their physician before taking any medicine.

Rotaflo

Brand Name:

Rotaflo

Generic Name:

Rotaflo

DESCRIPTION:

Rotaflo is a plastic inhalation device which is breath activated. This means when you inhale, the Rotaflo releases medication from the Rotacap.

INDICATIONS:

Rotaflo is an easy-to-use and a preferred device in patients with mild asthma and COPD, as well as in healthy participants with no previous experience of using inhalation devices.

PRESENTATION:

Rotaflo: Pack of 1’s

Patients should consult with their physician before taking any inhaler device.

Revolizer

Brand Name:

Revolizer

Generic Name:

Revolizer

DESCRIPTION:

Revolizer is a novel DPI device, which has been designed and developed to address the critical requirements of an ideal inhalation device. It provides accurate dosing and excellent lung deposition even at low inspiratory flow rates and is very easy to use and maintain.

INDICATIONS:

Revolizer is an easy-to-use and a preferred device in patients with mild asthma and COPD, as well as in healthy participants with no previous experience of using inhalation devices.

PRESENTATION:

Revolizer: Pack of 1’s.

Patients should consult with their physician before taking any inhaler device.

Rabecid

BRAND NAME:

Rabecid

GENERIC NAME:

Rabeprazole Sodium

COMPOSITION:

Rabecid 10mg Enteric-coated Tablet:
Rabeprazole sodium 10mg
Rabecid 20mg Enteric-coated Tablet:
Rabeprazole sodium 20mg

DESCRIPTION:

The active ingredient contains in Rabecid Tablets is Rabeprazole Sodium, which is substituted benzimidazole that inhibits gastric secretion.

INDICATION:

Rabecid is proton pump inhibitor indicated in adults for:

Treatment of non-erosive and erosive gastroesophageal reflux disease
Esophageal complication of reflux disease (Peptic stricture or Barrett’s esophagus)
Erosive esophagitis or esophageal Complications
Maintenance of healing of erosive or ulcerative GERD
Healing of gastric and duodenal ulcer
Helicobacter pylori eradication to reduce the risk of duodenal ulcer recurrence
Treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
H. Pylori associated Ulcer.

PRESENTATION:

Rabecid 10mg enteric-coated tablets: Blister pack of 1 X 14’s

Rabecid 20mg enteric-coated tablets: Blister pack of 1 X 14’s

Patients should consult with their physician before taking any medicine.

Hitica

Brand Name:

HITICA

Generic Name:

Ticagrelor

Composition:

Hitica 60mg Tablet:
Each film-coated tablet contains:
Ticagrelor 60mg
Hitica 90mg Tablet:
Each film-coated tablet contains:
Ticagrelor 90mg

Description:

HITICA is a prescription medicine used to reduce the rate of cardiovascular death, heart attack, and stroke in patients with the acute coronary syndrome (ACS) or a history of myocardial infarction (MI) & to reduce the rate of stent thrombosis in patients who have been stented for treatment of ACS.

INDICATIONS:

ACS patients on the prescription of a doctor

PRESENTATION:

Hitica 60mg, Hitica 90mg film-coated tablets: Alu-Alu Blister Pack of 1×10 tablets.

Apiban

Brand Name:

Apiban

Generic Name:

Apixaban

Composition:

Apiban 2.5mg Tablet: Each film-coated tablet contains:
Apixaban 2.5mg
Apiban 5mg Tablet: Each film-coated tablet contains:
Apixaban 5mg

Description:

Reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE). In patients who have undergone hip or knee replacement surgery. For the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy

INDICATIONS:

Nonvalvular Atrial Fibrillation. Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE),

Hip Or Knee Replacement Surgery, Recurrent DVT and PE

PRESENTATION:

2.5 mg and 5 mg in Blister Pack of 3×10’s tablets

Pidogrel-AP

Brand Name:

Pidogrel-AP

Generic Name:

Clopidogrel + Aspirin

Composition:

Pidogrel-AP 75mg Tablet: Each tablet contains:
Clopidogrel (as Clopidogrel Bisulphate) 75mg
Aspirin 75mg
Pidogrel-AP 150mg Tablet: Each tablet contains:
Clopidogrel (as Clopidogrel Bisulphate) 75mg
Aspirin 150mg

Description:

Clopidogrel + Asprin are inhibitors of platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets.

INDICATIONS:

Pidogrel is a P2Y12 platelet inhibitor indicated for Acute coronary syndrome and recent myocardial infarction

PRESENTATION:

Pidogrel-AP 75mg (75mg/75mg) and Pidogrel-AP 150mg (75mg/150mg) 1 x 10`s

Blokium DIU

Brand Name:

BLOKIUM & BLOKIUM DIU

Generic Name:

Atenolol + Chlorthalidone

Composition:

Blokium DIU 50 contains:
Atenolol 50 mg
Chlorthalidone 12.5mg

Blokium DIU 100 contains:
Atenolol 100 mg
Chlorthalidone 25mg

Description:

Atenolol is a beta-adrenergic blocking drug which acts preferentially on Beta Receptors in the heart

INDICATIONS:

Hypertensive patients and patients with angina pectoris on the prescription of a doctor

PRESENTATION:

Blokium DIU 100: Blister pack of 2×10. Blokium DIU 50: Blister pack of 2×10.

Misar AM

Brand Name:

Misar AM

Generic Name:

Telmisartan + Amlodipine

Composition:

Misar AM 40mg/5mg Tablet: Each tablet contains
Telmisartan 40mg
Amlodipine (as Besylate) 5mg
Misar AM 40mg/10mg Tablet: Each tablet contains
Telmisartan 40mg
Amlodipine (as Besylate) 10mg
Misar AM 80mg/ 5mg Tablet: Each tablet contains
Telmisartan 80mg
Amlodipine (as Besylate) 5mg
Misar AM 80mg/ 10mg Tablet: Each tablet contains

Telmisartan 80mg
Amlodipine (as Besylate) 10mg

Description:

Misar AM is a prescription medicine used with or without other antihypertensive agents or can be used as Initial therapy in uncontrolled hypertensive patients.

INDICATIONS:

Uncontrolled Hypertension

PRESENTATION:

Misar AM 40mg/5mg, 40mg/10mg, and 80mg/5mg tablets are present in packing of 2 X 7’s

Misar AM 80mg/10mg is present in packing of 10’s

Misar H

Brand Name:

Misar H

Generic Name:

Telmisartan+ Hydrochlorothiazide

Composition:

Misar H 40mg/12.5mg Tablet: Each tablet contains
Telmisartan 40mg
Hydrochlorothiazide 12.5mg
Misar H 80mg/12.5mg Tablet: Each tablet contains
Telmisartan 80mg
Hydrochlorothiazide 12.5mg
Misar H 80mg/25mg Tablet: Each tablet contains
Telmisartan 80mg
Hydrochlorothiazide 25mg

Description:

Essential Hypertension patients on the prescription of a doctor. Patients whose BP is not adequately controlled with telmisartan 80 mg monotherapy may be switched to telmisartan 80 mg/hydrochlorothiazide 12.5 mg once daily, and finally titrated up to 160/25mg, if necessary. Patients whose BP is inadequately controlled by hydrochlorothiazide 25 mg once daily may be switched to telmisartan 80 mg/hydrochlorothiazide 12.5 once daily. Those patients controlled by hydrochlorothiazide 25 mg but who experience hypokalemia with this regimen may be switched to telmisartan 80 mg/hydrochlorothiazide 12.5 mg once daily.

INDICATIONS:

Uncontrolled Hypertension

PRESENTATION:

Misar H 40mg/12.5mg and 80mg/12.5mg tablets in blister pack of 2 x 7’s

Racedo

Brand Name:

Racedo

Generic Name:

Racecadotrill

Composition:

Racedo 10mg Sachet:
Each sachet contains: Racecadotril 10mg
Racedo 30mg Sachet:
Each sachet contains: Racecadotril 30mg
Racedo 100mg Capsule:
Each capsule contains: Racecadotril 100mg

Description:

Racecadotril is an enkephalinase inhibitor that inhibits the breakdown of endogenous opioids, thus reducing secretions.

INDICATIONS:

It is indicated for the symptomatic treatment of acute diarrhoea in adults when causal treatment is not possible. If causal treatment is possible, it can be administered as a complementary treatment.

It is also indicated in infants (over 3 months old) and children as complementary symptomatic treatment of acute diarrhoea together with oral rehydration and the usual support measures, when these measures alone are insufficient to control the clinical condition, and when casual treatment is not possible.

PRESENTATION:

Racedo 10mg Sachets: Pack of 1 X 16’s

Racedo 30mg Sachets: Pack of 1 X 10’s

Racedo 10mg Capsules: Alu. Alu. Blister pack of 1 X 10’s

Fosbu V

Brand Name:

Fosbu V

Generic Name:

Sofosbuvir + Velpatasvir

Composition:

FOSBU V 400mg/ 100mg Tablet:
Each film-coated tablet contains:
Sofosbuvir 400mg
Velpatasvir 100mg

Description:

FOSBU V is a fixed-dose combination tablet containing sofosbuvir and velpatasvir for oral administration. Sofosbuvir is a nucleotide analog HCV NS5B polymerase inhibitor and velpatasvir is a NS5B inhibitor.

INDICATIONS:

FOSBU V (sofosbuvir and velpatasvir) is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1,2,3,4,5, or 6 infection: without cirrhosis or with compensated cirrhosis and with decompensated cirrhosis for use in combination with ribavirin.

DXL

Brand Name:

DXL

Generic Name:

Dexlansoprazole

Composition:

DXL 30mg Capsule: Each capsule contains: Dexiansoprazole
dual delayed-release pellets eq. to Dexlansoprazole 30mg
DXL 60mg Capsule: Each capsule contains: Dexiansoprazole
dual delayed-release pellets eq. to Dexlansoprazole 60mg

Description:

DXL belongs to a class of Anti-ulcerant drugs and is a new Class of Proton Pump Inhibitor with a unique and exclusive DDR technology. It is the R-enantiomer of Lansoprazole, which is composed of a racemic mixture of the R- and S-enantiomers. Compared to the older generation of PPIs (which includes Pantoprazole, Omeprazole, and Lansoprazole), Dexlansoprazole has a unique pharmacokinetic profile due to its delayed-release and dual-delivery release system. The active ingredient is released in two phases at different pH values and at different time points, resulting in two peak concentrations in the blood.

INDICATIONS:

Dexlansoprazole is indicated for healing all grades of erosive esophagitis (EE), maintaining and healing of EE and relief of heartburn, and treating heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD).

PRESENTATION:

DXL 30mg: Alu. Alu. Blister pack of 3 X 10’s capsules

DXL 60mg: Alu. Alu. Blister pack of 3 X 10’s capsules

Patients should consult with their physician before taking any medicine.

Emesson

Brand Name:

Emesson

Generic Name:

Ondansetron

Composition:

Emesson 4mg/2ml Injection: Each 2ml ampoule contains:
Ondansetron (as HCL Dihydarte) ——-4mg
Emesson 8mg/4ml Injection: Each 4ml ampoule contains.
Ondansetron (as HCL Dihydrate) ——-8mg

DESCRIPTION:

Ondansetron is a potent highly selective 5-HT3, receptor antagonist.

INDICATIONS:

In adults it is indicated for:

Prevention & Treatment of nausea & vomiting induced by cytotoxic chemotherapy & radiotherapy.
Prevention & Treatment of post-operative nausea & vomiting (PONV)

In Pediatric Population it is indicated for the:

Management of chemotherapy-induced nausea & vomiting (CINV) in children aged ≥ 6 months.
Prevention & treatment of PONV in children aged ≥ 1 month.

PRESENTATION:

Emesson Injection 8mg: Pack of Tray Blister 1’s & 5’s
Emesson Injection 4mg: Pack of Tray Blister of 1’s & 5’s

Evacef

Brand Name:

Evacef

Generic Name:

Cefadroxil

Composition:

Evacef 500mg Capsule:
Each capsule contains:
Cefadroxil (as Monohydrate) 500mg
Evacef 125mg/5mL Suspension:
Each 5mL contains:
Cefadroxil (as Monohydrate) 125mg
Evacef 250mg/5mL Suspension:
Each 5mL contains:
Cefadroxil (as Monohydrate) 250mg

DESCRIPTION:

Evacef (Cefadroxil Monohydrate, USP) is a first generation cephalosporin antibiotic intended for oral administration.

INDICATIONS:

Evacef (Cefadroxil) is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases:

Skin and Skin-Structure Infections caused by staphylococci and/or streptococci.
Urinary Tract Infections caused by E. coli, P. mirabilis and Klebsiella species.
Pharyngitis and/or Tonsillitis caused Streptococcus pyogenes (Group A beta-hemolytic streptococci)
Mild to moderate susceptible Gram positive Gram negative bacterial infections

PRESENTATION:

Evacef 500mg Capsules in pack of 2 X 6’s

Evacef 125mg/5mL Suspension in pack of 60mL and 90mL bottle

Evacef 250mg/5mL Suspension in pack of 60mL and 90mL bottle

Maxum

Brand Name:

Maxum

Generic Name:

Cefepime

Composition:

Maxum 500mg IM/IV injection: Each pack contains:
Vial: Cefepime (as Hydrochloride) 500mg
(with L-Arginine)
Ampoule: Sterile water for iniection USP 5mL
Maxum 1g IM/IV injection: Each pack contains:
Vial: Cefepime (as Hydrochloride) 1g
(with L-Arginine)
Ampoule: Sterile water for injection USP 10mL
Maxum 2g IV injection: Each pack contains:
Vial: Cefepime (as Hydrochloride) 2g
(with L-Arginine)
Ampoule: Sterile water for injection USP 10mL

DESCRIPTION:

Maxum (Cefepime) Injection is sterile, injectable product consisting of Cefepime Hydrochloride, a semi-synthetic, broad spectrum, cephalosporin antibiotic for parenteral administration.

Maxum 500mg Injection IM/IV
Maxum 1g Injection IM/IV
Maxum 2g Injection IV

INDICATIONS:

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Maxum (Cefepime) Injection and other antibacterial drugs, Maxum Injection should be used only to teat or prevent infections that are proven to strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy. It is used in the following conditions:

PNEUMONIA:

‘Maxum (Cefepime) Injection is indicated for pneumonia (moderate to severe) caused by Streptococcus pneumoniae, inducing cases associated with ‘concurrent bacteremia, Pseudomonas aeruginosa, Klebsiela pneumoniae, Enterobacter species.

EMPIRIC THERAPY FOR FEBRILE NEUTROPENIC PATENTS:

Maxum (Cefepime) Injection as monotherapy indicated for empiric treatment of febrile neutropenic patents. In paints a high risk for severe infection including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate.

UNCOMPLICATED AND COMPLICATED URINARY TRACT INFECTIONS (INCLUDING PYELONEPHRITIS):

Maxum (Cefepime) Injection is indicated for uncomplicated and complicated urinary tract infections caused by Escherichia coli or Klebsiella pneumoniae, when the infection is severe, or caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis, when the infection is mild to moderate, inducing cases associated with concurrent bacteremia with these bacteria.

UNCOMPLICATED SKIN AND KIN STRUCTURE INFECTIONS:

Maxum (Cefepime) is indicated for uncomplicated skin and skin structure infections caused by staphylococcus aureus or Streptococcus pyogenes,

COMPLICATED INTRA-ABDOMINAL INFECTIONS:

Maxum (Cefepime) Injection is indicated for complicated intra-abdominal infections (used in combination with metronidazole) caused by Escherichia coli viridians group streptococci, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter species, or Bacteroides fragilis.

PRESENTATION:

Maxum is supplied in following dosage forms, strengths and pack sizes:

MAXUM 500MG INJECTIONIM/IV:

1 vial of 500mg Cefepime and 1 ampoule of 5mL of water for injection

MAXUM 1G INJECTION IM/IV:

1 vial of 1g Cefepime and 1 ampoule of 10mL of water for injection

MAXUM 1G INJECTION IV:

1 vial of 2g Cefepime and 1 ampoule of 10mL of water for injection

Patients should consult with their physician before taking any medicine.

Fortez

Brand Name:

Fortez

Generic Name:

Ceftazidime

Composition:

Fortez 250mg IM/IV Injection: Each pack contains:
Vial: Ceftazidime Pentahydrate equivalent to Ceftazidime
250mg (with Sodium Carbonate)
Ampoule: Sterile water for injection USP 5mL
Fortez 500mg IM/IV Injection: Each pack contains:
Vial: Ceftazidime Pentahydrate equivalent to Ceftazidime 500 (with Sodium Carbonate)
Ampoule: Sterile water for injection USP 5mL
Fortez 1g IM/IV Injection: Each pack contains:
Vial: Ceftazidime Pentahydrate equivalent to Ceftazidime 1g
(with Sodium Carbonate)
Ampoule: Sterile water for injection USP 10mL
Fortez 2g IV Injection: Each pack contains:
Vial: Ceftazidime Pentahydrate equivalent to Ceftazidime 2g
(with Sodium Carbonate)
Ampoule: Sterile water for injection USP 10mL

DESCRIPTION:

Fortez contains Ceftazidime, a semisynthetic, third generation, broad-spectrum, beta-lactam antibacterial drug for parenteral administration.

INDICATIONS:

Fortez (Ceftazidime) is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases:

1. Bacterial Septicemia caused by Pseudomonas aeruginosa, Klebsiella spp., Hemophilus influenzae, Escherichia coli, Serratia spp., Streptococcus pneumoniae, and Staphylococcus aureus (methicillin-susceptible strains).

2. Bone and Joint Infections caused by Pseudomonas aeruginosa, Klebsiella spp., Enterobacter spp., and Staphylococcus aureus (methicillin-susceptible strains).

3. Gynecologic Infections, including endometritis, pelvic cellulitis, and other infections of the female genital tract caused by Escherichia coli.

4. Intra-abdominal Infections, including peritonitis caused by Escherichia coli, Klebsiella spp., and Staphylococcus aureus (methicillin-susceptible strains) and polymicrobial infections caused by aerobic and anaerobic organisms and Bacteroides spp. (many strains of Bacteroides fragilis are resistant).

5. Central Nervous System Infections, including meningitis, caused by Haemophilus influenzae and Neisseria meningitidis. Ceftazidime has also been used successfully in a limited number of cases of meningitis due to Pseudomonas aeruginosa and Streptococcus pneumoniae.

6. Prophylaxis for transurethral resection of prostate

7. Lower Respiratory Tract Infections, including pneumonia, caused by Pseudomonas aeruginosa and other Pseudomonas spp.; Hemophilus influenzae, including ampicillin-resistant strains; Klebsiella spp.; Enterobacter spp.; Proteus mirabilis; Escherichia coli; Serratia spp.; Citrobacter spp.; Streptococcus pneumoniae; and Staphylococcus aureus (methicillin-susceptible strains).

8. Post-surgical Infections caused by Pseudomonas aeruginosa; Klebsiella spp.; Escherichia coli; Proteus spp., including Proteus mirabilis and indole-positive Proteus; Enterobacter spp.; Serratia spp.; Staphylococcus aureus (methicillin-susceptible strains); and Streptococcus pyogenes (group A beta-hemolytic streptococci).

9. Urinary Tract Infections, both complicated and uncomplicated, caused by Pseudomonas aeruginosa; Enterobacter spp.; Proteus spp., including Proteus mirabilis and indole positive Proteus; Klebsiella spp.; and Escherichia coli.

10. Febrile neutropenia

11. Susceptible infections due to sensitive Gram-positive and Gram-negative bacteria, caused by pseudomonas species

It may be used alone in cases of confirmed or suspected sepsis. it may also be used concomitantly with other antibacterial drugs, such as aminoglycosides, vancomycin, and clindamycin; in severe and life-threatening infections; and in the immunocompromised patient. When such concomitant treatment is appropriate, prescribing information in the labeling for the other antibacterial drugs should be followed. The dose depends on the severity of the infection and the patient’s condition.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Fortez and other antibacterial drugs, Fortez should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

PRESENTATION:

FORTEZ 2G IM/IV INJECTION:

Vial containing powder and ampoule with 10mL water for injection

FORTEZ 1G IM/IV INJECTION:

Vial containing powder and ampoule with 10mL water for injection

FORTEZ 500MG IM/IV INJECTION:

Vial containing powder and ampoule with 5mL water for injection

FORTEZ 250MG IM/IV INJECTION:

Vial containing powder and ampoule with 10mL water for injection

Xorbact

Brand Name:

Xorbact

Generic Name:

Sulbactam sodium/cefoperazone sodium

Composition:

Xorbact 500mg IM/IV Injection:
Each pack contains
Vial: Cefoperazone Sodium equivalent to Cefoperazone 250mg, Sulbactam Sodium equivalent to Sulbactam 250mg
Ampoule: Sterile water for Injection USP 5ml
Xorbact 1g IM/IV Injection:
Each pack contains:
Vial: Cefoperazone Sodium equivalent to Cefoperazone 500mg, Sulbactam Sodium equivalent to Sulbactam 500mg
Ampoule: Sterile water for Injection USP 5ml
Xorbact 2g IM/IV Injection:
Each pack contains:
Vial: Cefoperazone Sodium equivalent to Cefoperazone 1g, Sulbactam Sodium equivalent to Sulbactam 1g
Ampoule: Sterile water for Injection USP 10ml

Description:

Sulbactam sodium/cefoperazone sodium combination is available as a dry powder for reconstitution in 1:1 in terms of free SBT/CPZ. Sulbactam sodium is a derivative of the basic penicillin nucleus. It is an irreversible beta-lactamase inhibitor for parenteral use only

INDICATIONS:

Monotherapy
Cefoperazone/sulbactam is indicated for the treatment of the following infections when caused by susceptible organisms: Respiratory tract infections (Upper and lower) Urinary tract infections (Upper and lower) Peritonitis, cholecystitis, cholangitis, and other Intra-abdominal infections Septicemia Meningitis Skin and soft tissue infections bone and joint infections Pelvic inflammatory disease, endometritis, gonorrhoea, and other infections of the genital tract
Combination Therapy
Because of the broad-spectrum activity of cefoperazone/sulbactam, most infections can be treated adequately with this antibiotic alone. However, cefoperazonelsulbactam may be used concomitantly with other antibiotics if such combinations are indicated. If an aminoglycoside is used, renal function should be monitored during the course of therapy

PRESENTATION:

Xorbact is supplied in the following dosage forms, strengths and pack sizes:
Xorbact Injection 500mg IM/IV:
1 vial of 250mg cefoperazone + 250mg sulbactam and 1 ampoule of 5ml water for injection.
Xorbact Injection 1g IM/IV:
1 vial of 500mg cefoperazone + 500mg sulbactam and 1 ampoule of 5ml water for injection.
Xorbact Injection 2g IM/IV:
1 vial of 1g cefoperazone + 1g sulbactam and 1 ampoule of 10ml water for injection.

Cefia

Brand Name:

Cefia

Generic Name:

Cefixime

Composition:

Cefia 200mg Capsule:
Each capsule contains: Cefixime (as trihydrate) 200mg
Cefia 400mg Capsule:
Each capsule contains: Cefixime (as trihydrate) 400mg
Cefia 100mg/5mL Suspension:
Each reconstituted 5mL contains: Cefixime (as trihydrate) 100mg
Cefia DS 200mg/5mL Suspension:
Each reconstituted 5mL contains: Cefixime (as trihydrate)200mg

DESCRIPTION:

Cefixime (Capsules/Suspension) is a semi-synthetic, Cephalosporin antibiotic for oral administration.

INDICATIONS:

Acute Exacerbations of Chronic Bronchitis (caused by Streptococcus pneumoniae and Hemophilus influenzae)
Community-acquired Pneumonia
Uncomplicated urinary tract infections (caused by Escherichia coli and Proteus mirabilis)
Pyelonephritis
In the treatment of otitis media (caused by Hemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes), sinusitis, pharyngitis & tonsillitis (caused by Streptococcus pyogenes)
Uncomplicated gonorrhea (cervical, urethral) caused by Neisseria gonorrhoeae (penicillinase-and non-penicillinase-producing isolates)

The use of cefixime should be reserved for infections where the causative Organism is known or suspected to be resistant to other commonly used antibiotics or where treatment failure may carry significant risk.

PRESENTATION:

Cefia 200mg Capsules in packs of 2 X 5’s

Cefia 400mg Capsules in packs of 1 X 5’s

Cefia 100mg/5mL Suspension in pack of 30mL and 60mL bottle

Cefia DS 200mg/5mL Suspension in pack of 30mL bottle

Patients should consult with their physician before taking any medicine.

Ceftro

Brand Name:

Ceftro

Generic Name:

Ceftriaxone Sodium

COMPOSITION:

Ceftro 250mg IM Injection:
Vial: Ceftriaxone 250mg
Ampoule: 1% Lignocaine HCI USP 2mL

Ceftro 250mg IV Injection:
Vial: Ceftriaxone 250mg
Ampoule: Sterile water for injection USP 5mL

Ceftro 500mg IM Injection:
Vial: Ceftriaxone 500mg
Ampoule: 1% Lignocaine HCI USP 2mL

Ceftro 500mg IV Injection:
Vial: Ceftriaxone 500mg
Ampoule: Sterile water for injection USP 5mL

Ceftro 1g IV Injection:
Vial: Ceftriaxone 1g
Ampoule: Sterile water for injection USP 10mL

Ceftro 2g IV Injection:
Vial: Ceftriaxone 2g
Ampoule: Sterile water for injection USP 20mL

INDICATION:

Hypertensive patients and patients with angina pectoris on the prescription of a doctor

PRESENTATION:

Ceftro is supplied in following dosage forms, strengths and pack sizes.

Tiovair-F

Brand Name:

Tiovair-F

Generic Name:

Tiotropium + Formoterol Fumarate

Composition:

Tiovair-F Rotacap: Each capsule contains:
Tiotropium (as Bromide Monohydrate) 18 mcg Formoterol Fumarate (as Dihydrate) 12 mcg

DESCRIPTION:

It is a synthetic, non-chiral, quaternary ammonium compound. It is sparingly soluble in water and soluble in methanol. The dry powder formulation within the Tiovair capsule is intended for oral inhalation only. The drug substance, tiotropium bromide monohydrate, is an anticholinergic with specificity for muscarinic receptors.

INDICATIONS:

Tiovair is indicated as a long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), and for reducing COPD exacerbations.

PRESENTATION:

Available as dry powder inhalation capsules. Tiovair: Tiotropium 18 mcg Each sale pack contains 20 dry powder inhalation capsules.

Patients should consult with their physician before taking any medicine.

Lipirex

Brand Name:

Lipirex

Generic Name:

Atorvastatin

Composition:

Lipirex 10mg Film coated Tablet:
Atorvastatin (as Calcium Trihydrate salt) 10mg
Lipirex 20mg Film coated Tablet:
Atorvastatin (as Calcium Trihydrate salt) 20mg
Lipirex 40mg Film coated Tablet:
Atorvastatin (as Calcium Trihydrate salt) 40mg

DESCRIPTION:

Patients with elevated LDL-cholesterol, apolipoprotein B, and triglycerides, and to increase HDL cholesterol

INDICATIONS:

Elevated LDL-cholesterol, apolipoprotein B, and triglycerides

PRESENTATION:

Lipirex 10mg, 20mg, and 40mg in blister pack of 10’s

Loprin

BRAND NAME:

Loprin

GENERIC NAME:

Enteric-coated Aspirin

COMPOSITION:

Loprin 75mg Tablet:
Each enteric-coated tablet contains Aspirin 75mg
Loprin 150mg Tablet:
Each enteric-coated tablet contains Aspirin 150mg

DESCRIPTION:

Loprin (Enteric-coated Aspirin) is a prescription medicine used to: ISH (Ischemic Heart Disease) and stroke

PRESENTATION:

Loprin 75mg and 150mg enteric-coated tablets blister pack of 30 tablets

Misar

Brand Name:

Misar

Generic Name:

Telmisartan

Composition:

Misar 20mg Tablet: Each film-coated tablet contains:
Telmisartan 20mg
Misar 40mg Tablet: Each film-coated tablet contains:
Telmisartan 40mg
Misar 80mg Tablet: Each film-coated tablet contains:
Telmisartan 80mg

Description:

Misar (Telmisartan) tablets are for once-daily oral administration and should be taken with liquid, with or without food. Precautions are to be taken before handling or administering the medicinal product. Misar (Telmisartan) should be kept in the sealed blister due to the hygroscopic property of the tablets. Tablets should be taken out of the blister shortly before administration.

INDICATIONS:

Hypertension

PRESENTATION:

Misar 20mg, 40mg, and 80mg tablets in blister pack of 2 x 7’s

Triforge

BRAND NAME:

Triforge

GENERIC NAME:

Amlodipine + Valsartan + Hydrochlorothiazide

COMPOSITION

Triforge 5mg/160mg/ 12.5mg Tablet:
Each film-coated tablet contains:
Amlodipine (as besylate) 5mg
Valsartan 160mg
Hydrochlorothiazide 12.5mg
Triforge 5mg/160mg/25mg Tablet:
Each film-coated tablet contains:
Amlodipine (as besylate) 5mg
Valsartan 160mg
Hydrochlorothiazide 25mg
Triforge 10mg/160mg/12.5mg Tablet:
Each film-coated tablet contains:
Amlodipine (as besylate) 10mg
Valsartan 160mg
Hydrochlorothiazide 12.5mg
Triforge 10mg/160mg/25mg Tablet:
Each film-coated tablet contains:
Amlodipine (as besylate) 10mg
Valsartan 160mg
Hydrochlorothiazide 25mg
Triforge 10mg/320mg/25mg Tablet:
Each film-coated tablet contains:
Amlodipine (as besylate) 10mg
Valsartan 320mg
Hydrochlorothiazide 25mg

DESCRIPTION

Triforge (Amlodipine +Valsartan + Hydrochlorothiazide) is a prescription medicine used to: Hypertension

INDICATION

Hypertensive patients on prescription of a doctor

Brand Name:

Omsta

Generic Name:

Omeprazole

Composition:

Omsta 20mg Capsule: Each capsule contains (as enteric-coated pellets) 20mg
Omsta 40mg Capsule: Each capsule contains (as enteric-coated pellets) 40mg

Description:

Omsta (Omeprazole) is a proton pump inhibitor.

INDICATIONS:

Omsta (omeprazole) capsules is indicated for short-term treatment of active duodenal ulcer in adults. Most patients heal within four weeks of therapy.
Omsta (omeprazole) capsule is indicated in Helicobacter pylori eradication to reduce the risk of duodenal ulcer recurrence.
Omsta (omeprazole) is indicated for short term treatment (4 to 8 weeks) of active benign gastric ulcer in adults.
Omsta (omeprazole) is indicated for the treatment of heartburn and other symptoms associated with GERD for up to 4 weeks in patients 1 year of age and older.
Omsta (omeprazole) is indicated in pediatric patients 1 year of age to adults for short term treatment (4 to 8 weeks) of Erosive Esophagitis (EE) due to acid mediated GERD that has been diagnosed by endoscopy in patients 1 year of age and older.
Omsta (omeprazole) is indicated in pediatric patients 1 month to less than 1 year of age for short term treatment (up to 6 weeks) of EE due to acid mediated GERD.
Omsta is indicated for the long term treatment of pathological hypersecretory conditions (e.g Zollinger-Ellison syndrome, multiple endocrine adenomas and systemic mastocytosis) in adults.

PRESENTATION:

1. Omsta 20mg Capsules: Blister Pack of 2×7’s tablets. 2. Omsta 40mg Capsules: Blister Pack of 2×7’s tablets.

Patients should consult with their physician before taking any medicine.

Menu

Media Center

Brand Name:

Generic Name:

Composition:

DESCRIPTION:

INDICATIONS:

PRESENTATION:

Brand Name:

Generic Name:

DESCRIPTION:

INDICATIONS:

PRESENTATION:

Brand Name:

Generic Name:

Composition:

DESCRIPTION:

INDICATIONS:

PRESENTATION:

Brand Name:

Generic Name:

Composition:

Description:

INDICATIONS:

PRESENTATION:

Brand Name:

Generic Name:

Composition:

Description:

INDICATIONS:

PRESENTATION:

Brand Name:

Generic Name:

Composition:

DESCRIPTION:

INDICATIONS:

PRESENTATION:

Brand Name:

Generic Name:

Composition:

DESCRIPTION:

INDICATIONS:

PRESENTATION:

Brand Name:

Generic Name:

Composition:

DESCRIPTION:

INDICATIONS:

PRESENTATION:

Brand Name:

Generic Name:

Composition:

DESCRIPTION:

INDICATIONS:

PRESENTATION:

Brand Name:

Generic Name:

Composition:

Description:

INDICATIONS:

PRESENTATION:

BRAND NAME:

GENERIC NAME:

COMPOSITION

DESCRIPTION:

INDICATION:

PRESENTATION:

BRAND NAME:

GENERIC NAME:

COMPOSITION

DESCRIPTION:

INDICATION:

PRESENTATION:

Brand Name:

Generic Name:

COMPOSITION:

DESCRIPTION:

INDICATIONS:

PRESENTATION:

Brand Name: